Cardiac myocyte apoptosis

European Heart Journal

Volumn 20, Issue 22, 1999, Pages 1619-1629

  Cook, S A ^a,b   Poole Wilson, P A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Caspase; Mitogen activated protein kinases; TUNEL

Indexed keywords

CASPASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE B; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CONGENITAL HEART MALFORMATION; DNA NICK TRANSLATION; GENE ACTIVITY; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033230297     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1548     Document Type: Review

References (90)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer. 26:1971;239-257.
2. Wyllie AH, Duvall E. Cell injury and death. In: McGee JO'D, Isaacson PG, Wright NA, eds. Oxford Textbook of Pathology. 1992;William Collins & Sons & Co, Glasgow. p. 142-57.
3. Yuan J. Evolutionary conservation of genetic pathway of programmed cell death. J Cell Biochem. 60:1996;4-11.
4. Allen RT, Hunter WJ, Agrawal DK. Morphological and biochemical characterisation and analysis of apoptosis. J Pharmacol Toxicol Methods. 37:1997;215-228.
5. Vermes I, Haanen C, Steffens Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidyl-serine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 184:1995;39-51.
6. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet. 10:1994;41-42.
7. Chiu L, Cherwinski H, Ransom J, Dunne JF. Flow cytometric ratio analysis of the Hoescht 33342 emission spectrum: multiparametric characterisation of apoptotic lymphocytes. J Immunol Methods. 189:1996;157-171.
8. Frey T. Nucleic acid dyes for detection of apoptosis in live cells. Cytometry. 21:1995;265-274.
9. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
10. Negoescu A. TUNEL: Improvement and evaluation of the method for In Situ Apoptotic cell identification. Biochemica. 2:1997;12-17.
11. Buja LM, Entman ML. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation. 98:1998;1355-1357.
12. Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science. 281:1998;1322-1326.
13. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 326:1998;1-16.
14. Sakahira H, Enari E, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
15. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
16. Cleveland JL, Ihle JN. Contenders in Fas/TNF cell signalling. Cell. 81:1998;479-482.
17. Yue T-L, Wang C, Romanic A. Staurosporine-induced Apoptosis in Cardiomyocytes: A Potential role for Caspase-3. J Mol Cell Cardiol. 30:1998;495-507.
18. Black SC, Huang JQ, Rezaiefar P. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischaemia and reperfusion in the rat. J Mol Cell Cardiol. 30:1998;733-742.
19. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischaemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
20. Meldrum DR. Tumour necrosis factor in the heart. Am J Physiol. 274:1998;R577-R595.
21. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome- c. J Biol Chem. 273:1998;16589-16594.
22. linteracts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A. 95:1998;4386-4391.
23. Cai J, Jones DP. Superoxide in Apoptosis. J Biol Chem. 273:1998;11401-11404.
24. Stridh H, Kimland M, Jones DP, Orrenius S, Hampton MB. Cytochrome- c release and caspase activation in hydrogen peroxide- and tributylin-induced apoptosis. FEBS Lett. 429:1998;351-355.
25. Kuida K, Haydar TF, Kuan C-Y. Reduced Apoptosis and Cytochrome- c Mediated Caspase Activation in Mice Lacking Caspase 9. Cell. 94:1998;325-337.
26. Green DR, Reed JC. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
27. Otter I, Conus S, Ravn U. The binding properties and the biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli. J Biol Chem. 273:1998;6110-6120.
28. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO. 17:1998;3878-3885.
29. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell. 74:1998;609-619.
30. land Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
31. Maundrell K, Antonsson B, Magnenant E. BCL-2 undergoes phosphorylation by c-JUN N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J Biol Chem. 272:1997;25238-25242.
32. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin Type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 272:1997;19022-19026.
33. Gajewski TF, Thompson CB. Apoptosis meets signal transduction. Elimination of a BAD Influence. Cell. 87:1996;589-592.
34. Datta SR, Dudek H, Tao X. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
35. Zhou H, Summers SA, Birnbaum JM, Pittman RN. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis. J Biol Chem. 273:1998;16568-16575.
36. Wang H, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell. 87:1996;629-638.
37. Scheid MP, Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and the activation of PKB/akt: Involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci U S A. 95:1998;7439-7444.
38. Kirshenbaum LA, de Moissac D. The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation. 96:1997;1580-1585.
39. Olivetti G, Abbi R, Quaini F. Apoptosis in the failing human heart. N Engl J Med. 336:1997;1131-1141.
40. Krown K, Page TP, Nguyen C. Tumour necrosis factor alpha-induced apoptosis in cardiac myocytes. J Clin Invest. 98:1996;2854-2865.
41. Aikawa R, Komuro I, Yamazaki T. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest. 100:1997;1813-1812.
42. Wu C, Bishopric NH, Pratt RE. Atrial naturetic peptide induces apoptosis in neonatal rat cardiac myocytes. J Biol Chem. 272:1997;14860-14866.
43. Tanaka M, Ito H, Adachi S. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
44. Cheng W, Li B, Kajstura J. Stretch-induced programmed myocyte cell death. J Clin Invest. 96:1995;2247-2259.
45. Robb MacLellan W, Schneider MD. Death by design. Circ Res. 81:1997;137-144.
46. French L, Hahne M, Viard I. Fas and Fas ligand in embryos and adult mice : ligand expression in several immune-priviliged tissues and coexpression in adult tissues characterised by apoptotic cell turnover. J Cell Biol. 133:1998;335-343.
47. Schlegel J, Peters I, Orrenius S. CPP32/Apopain Is a Key Interleukin-1β converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem. 271:1996;1841-1844.
48. Martin DA, Siegel RM, Zheng L, Lenardo MJ. Membrane oligomerization and cleavage activates the Caspase-8 (FLICE/MACHα1) death signal. J Biol Chem. 273:1998;4345-4349.
49. Granville DJ, Carthy CM, Hunt DWC, McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest. 78:1998;893-913.
50. Irmler M, Thome M, Hahne M. Inhibition of death-receptor signals by cellular FLIP. Nature. 388:1997;190-195.
51. Gotoh Y, Cooper JA. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumour necrosis factor-α signal transduction. J Biol Chem. 273:1998;17477-17482.
52. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor alpha in severe congestive cardiac failure. Br Heart J. 70:1993;141-143.
53. Toyozaki T, Hiroe M, Tanaka M, Nagata S, Ohwada H, Marumo F. Levels of soluble Fas ligand in myocarditis. Am J Cardiol. 82:1998;246-248.
54. Nishigaki K, Minatoguchi S, Seishima M. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 29:1997;1214-1220.
55. Evan G, Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1321.
56. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 79:1996;162-173.
57. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trend Cell Biol. 7:1997;353-361.
58. Sugden PH, Clerk A. `Stress-responsive' mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 83:1998;345-352.
59. ARFlinks tumour suppressor p53 to Ras. Nature. 395:1998;125-126.
60. Pierzchalski P, Reiss K, Cheng W. p53 Induces Myocyte Apoptosis via the Activation of the Renin-Angiotensin System. Exp Cell Res. 234:1997;57-65.
61. Bialik S, Geenen D, Sasson IE. Myocyte Apoptosis During Acute Myocardial Infarction in the Mouse Localises to Hypoxic Regions but Occurs Independently of p53. J Clin Invest. 100:1997;1363-1372.
62. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signalling. 9:1997;337-351.
63. Wang X, Martindale JL, Liu Y, Holbrook NJ. The cellular response to oxidative stress: influences of the mitogen-activated protein kinase signalling pathways on cell survival. Biochem J. 333:1998;291-300.
64. Guo Y-L, Baysal K, Kang B, Yang L-J, Williamson JR. Correlation between Sustained c-Jun N-terminal Protein Kinase Activation and Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial Cells. J Biol Chem. 273:1998;4027-4034.
65. Li GW, Zaheer A, Coppey L, Oskarsson HJ. Activation of JNK in the remote myocardium after large myocardial infarction in rats. Biochem Biophys Res Commun. 246:1998;816-820.
66. Ichijo H, Nishida E, Irie K. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signalling pathways. Science. 275:1998;90-94.
67. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci U S A. 94:1997;2869-2873.
68. Nemoto S, Xiang J, Huang S, Lin A. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J Biol Chem. 273:1998;16415-16420.
69. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown J, Chien KR. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase dependent pathway. J Biol Chem. 9:1997;5783-5791.
70. Roulston A, Reinhard C, Amiri P, Williams LT. Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in the response to tumor necrosis Factor-α J Biol Chem. 273:1998;10232-10239.
71. Koseki T, Inohara N, Chen S, Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A. 95:1998;5156-5160.
72. Deveraux QL, Roy N, Stennicke HR. IAPs block apoptotic events induced by caspase-8 and cytochrome- c by direct inhibition of distinct caspases. EMBO. 17:1998;2215-2223.
73. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-κB induction by TNF, CD-95 and IL-1. Nature. 385:1997;540-544.
74. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumour necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci U S A. 94:1997;10057-10062.
75. Narula J, Haider N, Virmani R. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
76. Olivetti G, Quaini F, Sala R. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J Mol Cell Cardiol. 28:1994;2005-2016.
77. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinene M, Voipio-Pulkki L-M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323.
78. Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 335:1996;1224-1226.
79. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P. Apaf-1 (CED-4 Homolog) Regulates Programmed Cell Death in Mammalian Development. Cell. 94:1998;727-737.
80. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 148:1996;141-149.
81. Kajstura J, Zhang X, Liu Y. The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 92:1995;2306-2317.
82. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol. 272:1997;H2313-H2319.
83. Kajstura J, Cheng W, Reiss K. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 74:1996;86-107.
84. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
85. Ambrosio G, Zweier JL, Becker LC. Apoptosis is prevented by administration of superoxide dismutase in dogs with reperfused myocardium. Basic Res Cardiol. 93:1998;94-96.
86. Piot CA, Padmanaban D, Ursell PC, Sievers RE, Wolfe CL. Ischaemic Preconditioning Decreases Apoptosis in Rat Hearts In Vivo. Circulation. 96:1997;1598-1604.
87. Cohen MZ. Free radicals in ischaemic and reperfusion myocardial injury: is this the time for clinical trials? Annals of Internal Medicine. 111:1989;918-931.
88. 2αin Pericardial Fluid of Patients With Heart Failure. Circulation. 97:1998;1536-1539.
89. Feuerstein G, Bril A, Ruffolo R. Protective effects of carvedilol in the myocardium. Am J Cardiol. 80:1997;41L-45L.
90. Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. Eur Heart J. 18:1997;560-565.